Abstract
25 albino rats of Wistar strain were used for the study. They were divided into three groups. Animals of the first group (n = 10) were treated with Diphenylhydantoin in a daily dose of 70mg/kg for three months. Animals of the second group (n = 10) were treated with Diazepam in a daily dose of 10 mg/kg for 3 months. Animals of the third group (n = 5) were treated with 5% acacia oil for the same period of time.
Food and water consumption together with motor activity were measured. As indices of enzyme induction, D-Glucaric acid and liver weight were determined. Also the following bone indices were determined: femur Ca/femur weight, femur Ca/body weight, humerus Ca/humerus weight, humerus Ca/body weight, femur specific weight, humerus specific weight.
Statistically significant alterations of bone mass were found.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bаrkа, T., Popper, H.: Liver enlargement and drug toxicity. Medicine (Baltimore) 46, 103 (1967)
Dent, C. E., Richens, A., Rowle, D. J. F., Stamp, T. C. B.: Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br. Med. J. 4, 69–72 (1970)
Christiansen, C., Rodbro, R., Lund, M.: Effects of vitamin D on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants: a controlled therapeutic trial. Br. Med. J. 2, 208–209 (1973)
Hahn, T. J., Hendin, B. A. et al.: Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults. New Engl. J. Med. 287, 900–904 (1972)
Hunter, J., Maxwell, J. D., Stewart, D. A. et al.: Altered calcium metabolism in epileptic children on anticonvulsants. Br. Med. J. 4, 202–204 (1971)
Ibbotson, R. N., Dilena, B. A., Horwood, J. M.: Studies on deficiency and absorption of folates in patients on anticonvulsant drugs. Aust. Ann. Med. 16, 144–150 (1967)
Marsh, C. A.: Metabolism of D-Glucuronolactone in Mammalian Systems. Indentification of D-Glucaric acid as a normal constituent of urine. Biochem. J. 86, 77 (1963)
Noach, E. L., Woodbury, D. M., Goodman, L. S.: Studies on the absorption, distribution, fate and excretion of 4-C14-labeled Diphenylhydantoin. J. Pharm. Exp. Ther. 122, 301–14 (1958)
Schwartz, M. A. et al.: Metabolism of Diazepam in rat, dog and Man. J. Pharmacol. Exp. Ther. 149, 423–435 (1965)
Sotaniemi, E. A. et al.: Glucaric acid as an indicator of use of enzyme inducing drugs. Clin. Pharmac. and Therapeutics 15, 417 (1973)
Wilson, C., Gisvoldo, O., Doerge, R.: Textbook of Organic Medicinal and Pharmaceutical Chemistry, 6th edition, p. 947. Philadelphia-Toronto: J. B. Libbincott Co. 1971
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag
About this paper
Cite this paper
Tesseromatis, C., Galanopoulou, P., Varonos, D. (1980). Influence of Liver Enzyme Induction Caused by Diphenylhydantoin and Diazepam on Bone Mass of Rats. In: Chambers, P.L., Klinger, W. (eds) Further Studies in the Assessment of Toxic Actions. Archives of Toxicology, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67729-8_117
Download citation
DOI: https://doi.org/10.1007/978-3-642-67729-8_117
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-10191-8
Online ISBN: 978-3-642-67729-8
eBook Packages: Springer Book Archive